Biosciences firms' take on the recession: Not as bad as everyone else

December 16, 2008 | Analyst Insight

From our recent conversation with 5AM Ventures Managing Partner Andy Schwab to press releases from DSM and Bayer, investors and developers at the forefront of biosciences feel set to take the...